Anadolu Medical Center
Anadolu Medical Center
Turkey, Istanbul
Zafer Gulbas
49 years of experience • 3315+ treatments performed
accreditations :
Clinic is certified :
| Turkey | Austria | Spain | |
| HLA-typing | from $200 | from $500 | from $200 |
No hidden fees – just official clinic prices. Pay at the clinic for HLA-typing upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in HLA-typing and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your HLA-typing journey.
Professor Zafer Gulbas leads one of the largest bone marrow transplant centers in Europe. He performs essential HLA-typing to match patients with donors for life-saving stem cell transplants.
Dr. Ceyhun Bozkurt is a pediatric hematologist-oncologist at Medical Park Bahcelievler Hospital. He serves as the clinical director and vice director of the stem cell transplant unit. Dr. Bozkurt focuses on childhood leukemia, bone marrow transplants, and neuroblastoma. He completed specialized observerships at Harvard University and Cincinnati Children's Hospital.
Dr. Bulent Unal is a surgical oncologist and transplant surgeon at Istanbul Florence Nightingale Hospital. He previously worked as an NCI Short-Term Scientist at the University of Pittsburgh Medical Center. Dr. Unal focuses on breast cancer techniques like ductoscopy and sentinel node applications. He has published research on liver transplant outcomes and complex oncologic procedures.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.